These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10401026)

  • 21. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
    Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study.
    Marcus R; Krause L; Weder AB; Dominguez-Meja A; Schork NJ; Julius S
    Circulation; 1994 Aug; 90(2):928-36. PubMed ID: 8044964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P; Siriwiwatanakul N
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.
    Covic A; Mardare NG; Ardeleanu S; Prisada O; Gusbeth-Tatomir P; Goldsmith DJ
    J Nephrol; 2006; 19(6):783-93. PubMed ID: 17173253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension.
    Jula AM; Karanko HM
    Circulation; 1994 Mar; 89(3):1023-31. PubMed ID: 8124787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of left ventricular hypertrophy in patients with chronic kidney disease.
    Yilmaz BA; Mete T; Dincer I; Kutlay S; Sengül S; Keven K; Ertürk S
    Ren Fail; 2007; 29(3):303-7. PubMed ID: 17497444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the timing of dialysis initiation on left ventricular hypertrophy and ınflammation in pediatric patients.
    Bakkaloğlu SA; Kandur Y; Serdaroğlu E; Noyan A; Bayazıt AK; Sever L; Özlü SG; Özçelik G; Dursun İ; Alparslan C
    Pediatr Nephrol; 2017 Sep; 32(9):1595-1602. PubMed ID: 28396941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure.
    Greaves SC; Gamble GD; Collins JF; Whalley GA; Sharpe DN
    Am J Kidney Dis; 1994 Nov; 24(5):768-76. PubMed ID: 7977318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy and blood pressure control in automated and continuous ambulatory peritoneal dialysis patients.
    Ataş N; Erten Y; Okyay GU; Inal S; Topal S; Öneç K; Akyel A; Çelik B; Tavil Y; Bali M; Arınsoy T
    Ther Apher Dial; 2014 Jun; 18(3):297-304. PubMed ID: 24965296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
    Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of left ventricular hypertrophy in hemodialyzed patients is possible: a follow-up study.
    Ardeleanu Ş; Panaghiu L; Prisadă O; Sascău R; Voroneanu L; Hogaş S; Mardare N; Covic A
    Int Urol Nephrol; 2011 Dec; 43(4):1161-9. PubMed ID: 20658356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .
    Akaishi M; Hiroe M; Hada Y; Suzuki M; Tsubakihara Y; Akizawa T;
    J Cardiol; 2013 Oct; 62(4):249-56. PubMed ID: 23787155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease.
    Poulikakos D; Ross L; Recio-Mayoral A; Cole D; Andoh J; Chitalia N; Sharma R; Carlos Kaski J; Banerjee D
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):56-61. PubMed ID: 23811493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients.
    Io H; Matsumoto M; Okumura K; Sato M; Masuda A; Furukawa M; Nohara N; Tanimoto M; Kodama F; Hagiwara S; Gohda T; Shimizu Y; Tomino Y
    Semin Dial; 2011; 24(3):349-54. PubMed ID: 20723158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.